{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:46:52Z","timestamp":1780357612648,"version":"3.54.1"},"reference-count":38,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The growing interest of cannabidiol (CBD) in medical care prompted French health authorities to explore the potential of CBD in cancer-related severe symptoms. This study aimed to assess the prevalence of CBD use among cancer patients with potential associated factors and to measure the cancer patient's health literacy (HL) on CBD consumption.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a prospective study in oncology day-care hospital including patients from 29 October to 20 December 2021, we collected demographic, biological, and oncological characteristics. Patient CBD HL was measured by the hetero-questionnaire 8-item-CBD HL scale (HLS-8-CBD) whose conception has been validated by a psychometric analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 363 participants, 20 patients (5.5%) reported CBD use. Factors associated with CBD use were: age &lt;60 years (odd ratio\u2009=\u20097.80[1.36\u201313.32],\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u200910\n                      <jats:sup>\u22124<\/jats:sup>\n                      versus \u226560 years), smoking history (OR = 5.53[1.81\u201316.88],\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.01), and no smoking cessation (OR = 5.07[1.66\u201315.46],\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.01). CBD use was also associated with a better CBD total HL score than non-users (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      -value\u2009=\u20090.02).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Identification of factors associated with CBD use and a relatively high patient CBD HL in CBD users showed that CBD use in cancer patients care represented a new concern and should enhance health professionals to consider CBD with its associated drug-related problems.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10781552231187136","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T15:24:19Z","timestamp":1689175459000},"page":"3-13","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of cannabidiol (CBD) consumption and cancer patients\u2019 expectations in one oncology day-hospital: A cross-sectional study and questionnaire validation"],"prefix":"10.1177","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0789-5180","authenticated-orcid":false,"given":"Antoine","family":"Le Bozec","sequence":"first","affiliation":[{"name":"Oncology Day-Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Gu\u00e9don","sequence":"additional","affiliation":[{"name":"CHU Reims, Department of Pharmacy, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Brugel","sequence":"additional","affiliation":[{"name":"CHU Reims, Service de Gastroent\u00e9rologie et Oncologie Digestive, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeliss","family":"Laurent","sequence":"additional","affiliation":[{"name":"CHU Reims, Department of Pharmacy, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Carlier","sequence":"additional","affiliation":[{"name":"Oncology Day-Hospital"},{"name":"Institut Jean Godinot, D\u00e9partement d'Oncologie M\u00e9dicale, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Hettler","sequence":"additional","affiliation":[{"name":"CHU Reims, Department of Pharmacy, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Perrier","sequence":"additional","affiliation":[{"name":"CHU Reims, Service de Gastroent\u00e9rologie et Oncologie Digestive, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Aubert","sequence":"additional","affiliation":[{"name":"Oncology Day-Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Slimano","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Reims Champagne-Ardenne"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Mongaret","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Reims Champagne-Ardenne, BIOS, CHU Reims, Department of Pharmacy, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bouch\u00e9","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Reims Champagne-Ardenne, Biospect, CHU Reims, Oncology Day-Hospital, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2014.04.001"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092447"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.e24143"},{"key":"e_1_3_3_5_2","unstructured":"TD0217210ENN.pdf. https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/4135\/TD0217210ENN.pdf (accessed 7 April 2022)."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00482-015-0083-4"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1147"},{"key":"e_1_3_3_8_2","first-page":"32","article-title":"The pharmacology and therapeutic potential of cannabidiol","author":"Pertwee RG","year":"2004","unstructured":"Pertwee RG. The pharmacology and therapeutic potential of cannabidiol. Cannabinoids 2004; 5: 32\u201383.","journal-title":"Cannabinoids"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2005.08.026"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.3747\/co.23.3099"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/s42238-021-00102-z"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2011.0392"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01259"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.2174\/187152709789824660"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2022.02.001"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/0897190019828920"},{"key":"e_1_3_3_17_2","article-title":"Development of a rapid risk evaluation tool for herbs\/drugs interactions in cancer patients: a multicentric experience in south of France","volume":"26","author":"Pourroy B","year":"2017","unstructured":"Pourroy B, Letellier C, Helvig A, et al. Development of a rapid risk evaluation tool for herbs\/drugs interactions in cancer patients: a multicentric experience in south of France. Eur J Cancer Care 2017; 26: e12752.","journal-title":"Eur J Cancer Care"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2022.23.1.319"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/heapro\/dan017"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12199-013-0340-z"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2006.03.012"},{"key":"e_1_3_3_22_2","unstructured":"Coefficient alpha and the internal structure of tests. SpringerLink https:\/\/link.springer.com\/article\/10.1007\/BF02310555 (accessed 14 December 2021)."},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-021-06515-z"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2012.07.014"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.6358"},{"key":"e_1_3_3_26_2","article-title":"Efficacy and adverse effects of medical marijuana for chronic noncancer pain: systematic review of randomized controlled trials","volume":"61","author":"Deshpande A","year":"2015","unstructured":"Deshpande A, Mailis-Gagnon A, Zoheiry N, et al. Efficacy and adverse effects of medical marijuana for chronic noncancer pain: systematic review of randomized controlled trials. Can Fam Physician 2015; 61: e372\u2013e381.","journal-title":"Can Fam Physician"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2354.2008.00917.x"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2011.02.017"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.DMPK-12-RG-129"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2005.12.033"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2016.0034"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.2174\/1389200217666151210142051"},{"key":"e_1_3_3_33_2","article-title":"Comment on: Cannabis use among Danish patients with cancer: a cross-sectional survey of sociodemographic traits, quality of life, and patient experiences","author":"Vitetta L","unstructured":"Vitetta L, Sikali JF, Fletcher C, et al. Comment on: Cannabis use among Danish patients with cancer: a cross-sectional survey of sociodemographic traits, quality of life, and patient experiences. Support Care Cancer 2022; 30: 1181\u20131190. Epub ahead of print 21 March 2022.","journal-title":"Support Care Cancer"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-04832-y"},{"key":"e_1_3_3_35_2","unstructured":"Association of Health Literacy with Diabetes Outcomes. Diabetes. JAMA. JAMA Network https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/195143 (accessed 13 December 2021)."},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.05.043"},{"key":"e_1_3_3_37_2","article-title":"Use of complementary and alternative medicine: Prevalence and health literacy among patients attending a Health Centre in Universiti Teknologi MARA Selangor","volume":"1","author":"Sharoni SKA","unstructured":"Sharoni SKA, Robani S, Zaini SA. Use of complementary and alternative medicine: Prevalence and health literacy among patients attending a Health Centre in Universiti Teknologi MARA Selangor. Healthscope: The Official Research Book of Faculty of Health Sciences, UiTM. Vol.1. Healthscope, 2019. https:\/\/healthscopefsk.com\/index.php\/research\/article\/view\/8 (accessed 25 February 2022).","journal-title":"Healthscope: The Official Research Book of Faculty of Health Sciences, UiTM"},{"key":"e_1_3_3_38_2","first-page":"417","article-title":"Sex differentials in health","volume":"97","author":"Verbrugge LM","year":"1982","unstructured":"Verbrugge LM. Sex differentials in health. Public Health Rep 1982; 97: 417\u2013437.","journal-title":"Public Health Rep"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2648.2004.03331.x"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552231187136","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10781552231187136","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552231187136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:28:44Z","timestamp":1777688924000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10781552231187136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1177\/10781552231187136"],"URL":"https:\/\/doi.org\/10.1177\/10781552231187136","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,12]]}}}